Galmed Pharmaceuticals Ltd

Research Galmed Pharmaceuticals Ltd (GLMD) on Bullrun: market cap USD 3.77M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGLMD
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.77M
• Financial periodFY2025
• Net income-USD 10.31M

Valuation Snapshot

latest market cap is USD 3.77M.

About Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.

Frequently asked questions

What is Galmed Pharmaceuticals Ltd's market cap?

Galmed Pharmaceuticals Ltd's market capitalization is USD 3.77M.

What does Galmed Pharmaceuticals Ltd do?

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.